SCHEMBL4325237

SCHEMBL4325237

CC(NC(=O)c1nc(-c2cccc(Cl)c2)n2ccccc12)C(C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 5/20 0.54
CNR1 P21554 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
MAP3K14 Q99558 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CSNK2B P67870 1/20 0.39
CSNK2A1 P68400 1/20 0.39
MDM2 Q00987 2/20 0.39
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ATM Q13315 1/20 0.38
HAT1 O14929 2/20 0.38
EP300 Q09472 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4324710 0.83 CNR2 (0.45) CNR2CNR1L3MBTL1KDM4EALDH1A1
SCHEMBL13578094 0.83 CNR2 (0.58) CNR2CNR1L3MBTL1KDM4EALDH1A1
SCHEMBL4333497 0.82 CNR2 (0.57) CNR2CNR1L3MBTL1KDM4EALDH1A1
SCHEMBL4331255 0.82 CNR2 (0.45) CNR2CNR1KDM4EALDH1A1MAP3K14
SCHEMBL4323158 0.82 CNR2 (0.61) CNR2L3MBTL1KDM4EALDH1A1GAA
SCHEMBL4325441 0.80 MDM2 (0.40) CNR2L3MBTL1KDM4EALDH1A1GAA
SCHEMBL4329757 0.80 CNR2 (0.47) CNR2CNR1L3MBTL1KDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL4331110 0.80 CNR2 (0.54) CNR2CNR1L3MBTL1KDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL4324553 0.79 ATM (0.46) CNR2L3MBTL1NPC1RAB9AATM
Trifluoroacetic Acid SCHEMBL4329948 0.79 ATM (0.46) CNR2L3MBTL1NPC1RAB9AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325936-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES MERCK & CO., INC. 2009-12-31 US disclosed
US-20090325936-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES MERCK & CO., INC. 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325936-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES CNR2, CNR1, TRPV1 CNR2 1/4885CNR1 2/4885L3MBTL1 4825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.